November 08, 2021
German diagnostics giant Qiagen has agreed to pay $53 million to New Jersey medical technology manufacturer Becton Dickinson & Co. to resolve an infringement lawsuit against Qiagen over microfluidic testing patents that the Federal Circuit last month called too "complex" to invalidate.